ISO has acquired D2Hawkeye, Inc., a provider of information solutions for the healthcare industry. Solutions from D2Hawkeye include advanced healthcare analytics, data mining, decision support, clinical quality analysis, and risk analysis tools.
"D2Hawkeye advances ISO's leadership position in the healthcare analytics and predictive modeling market by providing proven tools to pinpoint and manage medical and financial risk across the healthcare continuum," says Frank J. Coyne, ISO chairman, president, and chief executive officer. "With its current market traction in healthcare risk analysis, D2Hawkeye is a leading solution for medical analytics and predictive modeling and a premier medical data-mining enterprise in the United States."
Founded in July 2001, D2Hawkeye is headquartered in Waltham, Mass., and has technology operations in South Asia. D2Hawkeye builds and manages integrated medical and financial databases for its customers, applies its proprietary evidence-based medical rules, and provides an ASP-based interface for medical analytics and reporting.
"Industry professionals use our tools to estimate cost and risk trends, to identify emerging high-risk consumers for optimal allocation of medical management resources and interventions, and to compare performance against industry benchmarks," says Chris Kryder, MD, chairman, CEO, and founder of D2Hawkeye. D2Hawkeye also provides medical advisory, medical analytics, benchmarking, and other healthcare information services.
D2Hawkeye will be combined with ISO's other healthcare businesses as a new subsidiary under Verisk Health. Chris Kryder will lead the new subsidiary as CEO. Verisk Health includes the healthcare enterprise business intelligence platform offered by Urix and DxCG's predictive modeling solutions. ISO acquired Urix in 2006 and DxCG in 2004.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.